Previous close | 113.23 |
Open | 113.23 |
Bid | 118.30 |
Ask | 121.60 |
Strike | 170.00 |
Expiry date | 2025-01-17 |
Day's range | 113.23 - 113.23 |
Contract range | N/A |
Volume | |
Open interest | 3 |
Avanos' (AVNS) first-quarter results show strong bottom-line improvement along with decent growth in segmental revenues.
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.